Evotec SE (EVO) Gross Margin (2009 - 2025)
Evotec SE (EVO) reported Gross Margin of 30.99% for Q4 2025, up 1015.0% on a YoY basis from 2.78% in Q4 2024, and up 100.08% sequentially from 37830.94% in Q3 2025.
Evotec SE (EVO) Gross Margin (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Gross Margin data on file, last reported at 30.99% in Q4 2025.
- For the quarter ending Q4 2025, Gross Margin rose 1015.0% year-over-year to 30.99%; the trailing twelve-month figure through Dec 2025 stood at 7811.12% (down 783135.0% YoY), and the FY2025 full-year result was 0.0%, down 1442.0% from the prior year.
- Gross Margin rose to 30.99% in Q4 2025, from 37830.94% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 30.99% in Q4 2025 to a low of 37830.94% in Q3 2025.
- A 5-year average of 2502.52% and a median of 19.61% in 2022 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 1015 bps in 2025, while the deepest fall reached 3784083 bps in 2025.
- Tracing EVO's Gross Margin over 5 years: stood at 23.08% in 2021, then slipped by 22 bps to 17.94% in 2022, then soared by 32 bps to 23.68% in 2023, then fell by 12 bps to 20.84% in 2024, then soared by 49 bps to 30.99% in 2025.
- Business Quant data shows EVO's Gross Margin at 30.99% in Q4 2025, 37830.94% in Q3 2025, and 20.84% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.99% |
| Sep 30, 2025 | -37,830.94% |
| Dec 31, 2024 | 20.84% |
| Sep 30, 2024 | 9.89% |
| Dec 31, 2023 | 23.68% |
| Sep 30, 2023 | 19.27% |
| Jun 30, 2023 | 24.93% |
| Dec 31, 2022 | 17.94% |
| Sep 30, 2022 | 16.34% |
| Jun 30, 2022 | 17.94% |
| Mar 31, 2022 | 19.61% |
| Dec 31, 2021 | 23.08% |
| Sep 30, 2021 | 27.04% |
| Jun 30, 2021 | 18.54% |
| Mar 31, 2021 | 23.05% |
| Dec 31, 2020 | 24.75% |
| Dec 31, 2019 | 29.77% |
| Sep 30, 2010 | 42.01% |
| Jun 30, 2010 | 49.75% |
| Mar 31, 2010 | 37.89% |